Table 2.
Summary of input data sources on ACh-mediated effects on the physiology of neocortical synaptic connections.
| Connection-type | Short-term dynamics | Experimental technique | Physiological effect | Reference |
|---|---|---|---|---|
| L23 PC → L23 BC | E2 Excitatory, depressing | Bath-application of ~5 μM of CCh in Rat S1 slices (P11–26) | Reduction of first PSP amplitude to ~60% of control | Levy et al. (2008) |
| L23 PC → L23 PC | E2 Excitatory, depressing | Bath-application of ~10 μM oxotremorine or muscarine in Rat A1 slices (P21–28) | Decreases first EPSC amplitude to ~53% of control | Atzori et al. (2005) |
| L4 excitatory → L4 excitatory | E2 Excitatory, depressing | Bath-application of ~100 μM ACh in Rat S1 slices (P18–24) | Diminishes first PSP amplitude to ~40% of control | Eggermann and Feldmeyer (2009) |
| L5 PC → L5 PC | E2 Excitatory, depressing | Bath-application of ~100–150 μM ACh in Rat S1 slices (P13–15) | Reduction of first PSP amplitude to ~25% of control | Tsodyks and Markram (1997) |
| L5 PC → L5 PC | E2 Excitatory, depressing | Bath-application of ~200 μM ACh in Rat S1 slices (P13–15) | Decreases first PSP amplitude to ~5% of control | Tsodyks and Markram (1997) |